Stay updated on Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial page.

Latest updates to the Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial page
- Check3 days agoChange DetectedA new revision entry (v3.6.2) was added to the page history, replacing the previous v3.6.0 entry. This indicates a version update to the study page, potentially reflecting small textual or formatting adjustments.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedNew navigation/help links were added to assist users in joining and understanding the study: Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, and How to Join a Study. The Interventions header was reformatted from 'Intervention / Treatment' to 'Intervention/Treatment', and the page revision label was updated to v3.6.0.SummaryDifference0.4%

- Check25 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5. This indicates a small site update with no changes to the study details.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page now lists Revision: v3.5.4, replacing the previous v3.5.3. This indicates a minor update to the page's revision/version metadata rather than changes to visible content.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page’s footer revision indicator was updated from **v3.5.2** to **v3.5.3**.SummaryDifference0.0%

- Check75 days agoChange DetectedAdded Revision: v3.5.2; Removed Revision: v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial page.